IBEX Limited (“ibex”), a leading global provider in business
process outsourcing and end-to-end customer engagement technology
solutions, today announced financial results for its second fiscal
quarter ended December 31, 2021.
“Our business is accelerating as our strategic
shift into the digital-first marketplace takes effect,” said Bob
Dechant, CEO of ibex. “In Q2, we delivered the highest quarterly
revenue in the company’s history, which represented a 12.8% growth
from prior year. Our business will continue to pick up pace in the
second half of the fiscal year, driven by growth from our
integrated omnichannel solutions across both our new and existing
clients. Revenues from our new customers since 2016, which
represent our strategic shift into the digital-first marketplace,
grew by an impressive 57% on a year over year basis and now
represent 70% of our total company revenue, up from 50% a year ago.
Our legacy 3 clients, which at the time of the IPO were our largest
3 clients and predominantly Telco, now represent less than 20% of
our total revenues, compared to 36% a year ago and 38% at the time
of our IPO. We are excited about the trajectory of the business for
the second half of FY22 and beyond due to the increasing dominance
in our top line by our more recent customer wins.”
Dechant continued, “I’m very excited about our
performance and outlook, particularly the robust and rapid
diversification of our client base. We've added exceptional
high-growth brands and today our top 5 clients represent 41% of our
business, versus approximately 54% at the time of our IPO, and we
now have nearly 50 clients with more than $1 million of annual
revenue. Our largest client represents just 12% of
revenue. The level of diversification is now a true
competitive advantage for Ibex and is exceptional for a BPO
provider of any size.
While revenue growth for the quarter was strong
and margins improved sequentially, adjusted EBITDA was flat on a
year-over-year comparison. This was driven primarily by the costs
associated with ramping our business such as agent training and
investment in overhead. Consequently, our EBITDA margin was down
year over year from 15.3% to 13.5%. We expect our overall margins
to improve in the second half of the year as our ramp training
costs stabilize.
In January, we also had a broadening of our
ownership structure. TRGI, our majority shareholder, retired a
portion of its share capital and approved the transfer of a portion
of the ibex shares held by TRGI to some of its shareholders. This
has reduced TRGI’s stake in ibex from 62% to 35%, which will
meaningfully broaden our public float over time. We welcome the
transition of the holdings in ibex of these new shareholders from
an indirect stake via TRGI to becoming direct ibex
shareholders.
Overall, we are very confident about the outlook
in our business. This was demonstrated by the recent share
repurchase announcement where our board authorized us to buy back
up to $20 million of our common shares, at what we expect will be a
very attractive IRR for our shareholders. Additionally, key members
of our Executive Leadership Team and Board, including myself,
participated in planned purchases in December.”
Second Quarter of Fiscal Year 2022 Financial
Highlights
Revenue
- Revenue increased 12.8% to $132.2
million, compared to $117.2 million in the prior year quarter.
- Revenue related to our new clients
won since FY16 grew 57% compared to the prior year quarter and now
represents 70% of our quarterly revenue.
- Our current quarter revenue growth
was partially impacted by decreases related to our legacy top 3
clients. Our legacy top 3 clients now represent less than 20% of
our revenue and consequently are expected to have less of an impact
on our revenue outlook.
Net Income
- Net income increased to $8.5
million, compared to $2.5 million in the prior year quarter. The
increase in net income was primarily driven by a decrease in the
fair value measurement related to the warrant liability offset by
an increase in depreciation as we continue to invest in the growth
of the business.
- Net income margin increased to
6.4%, compared to 2.1% in the prior year quarter.
- Non-GAAP adjusted net income was
$5.2 million, compared to $6.1 million in the prior year quarter
(see Exhibit 1 for reconciliation).
- Non-GAAP adjusted net income margin
decreased to 3.9%, compared to 5.2% in the prior year quarter (see
Exhibit 1 for reconciliation).
Adjusted EBITDA
- Non-GAAP adjusted EBITDA was $17.8
million, compared to $18.0 million in the prior year quarter (see
Exhibit 2 for reconciliation).
- Non-GAAP adjusted EBITDA margin was
13.5%, compared to 15.3% in the prior year quarter (see Exhibit 2
for reconciliation).
- Adjusted EBITDA margin decreased
primarily due to costs associated with ramping our business such as
agent training and investment in overhead.
Earnings Per Share
- IFRS basic and
fully diluted earnings per share were $0.46 and $0.45,
respectively, compared to $0.14 and $0.13, respectively, in the
prior year quarter.
- Non-GAAP adjusted fully diluted
earnings per share were $0.27, compared to $0.33 in the prior year
quarter (see Exhibit 1 for reconciliation).
Cash Flow and Balance Sheet
-
Cash flow from operations was $3.4 million, compared to $4.3
million in the prior year quarter.
-
Capex increased to $11.8 million, compared to $6.4 million in the
prior year quarter, as we invest for the future
and expand our capacity across existing and new
geographies.
-
Cash and cash equivalents were $51.5 million, total borrowings were
$37.7 million, and lease liabilities were $89.4 million as of
December 31, 2021, compared to cash and cash equivalents of $57.8
million, total borrowings of $28.5 million, and lease liabilities
of $84.0 million as of June 30, 2021.
Business Highlights
- Won three new clients in the
quarter and twelve in the fiscal year-to-date. We expect our new
clients that launched this year to generate in-year revenue of more
than $50 million, which will represent a 66% increase from the
in-year revenues from new clients in the prior fiscal year. Our
past cohort trends indicate that annual revenues from new clients
increase by a factor of 2.5-3.5x from year one to year two. We
expect this trend to continue for our cohort of new clients in
fiscal 2022 at a slightly more moderated level of 2x, which will
provide a strong revenue driver for the next few years.
- Revenue generated from FinTech and
Healthcare (our two strategic investment verticals since FY20)
increased 100% from the prior year quarter and now represent 20% of
our business. These verticals are on track to generate over $100
million of annual revenues in fiscal 2022, compared to $44 million
only two years ago.
- Legacy top 3 client concentration
decreased to 19.9% of revenue from 36% in the prior year.
- Telecommunications vertical
decreased to 17.2% of revenue from 30% in the prior year.
- Added over 2,500 seats in high
margin nearshore and offshore locations.
- Successfully launched in a new
region, Honduras, with a strategic client and over 250
employees.
- ibex Cares raised over $200,000 for
our team members affected by the devastating Typhoon Odette (Rai)
in the Philippines, with 50% of the funds raised by our very own
team members.
Fiscal Year 2022 Business Outlook
We are raising our revenue guidance while
reaffirming adjusted EBITDA and capex guidance for our fiscal year
2022.
- Raising fiscal year 2022 organic revenue growth to 10% to 12%
from 7% to 9% previously. Revenue growth will continue to
accelerate as we onboard new capacity.
- Reaffirming adjusted EBITDA guidance of $69.0 million to $71.0
million.
- Reaffirming capex guidance of $30.0 million to $35.0 million.
We expect to return to lower capex spend when social distancing
restrictions subside.
Share Repurchase Authorization
During the quarter, the company’s board of
directors has authorized the repurchase of up to $20 million of the
company’s common shares. As of February 15, the company has
repurchased $1.3 million of its common shares at an average price
of $13.95 per share.
Conference Call and Webcast Information
IBEX Limited will host a conference call and
live webcast to discuss its second quarter of fiscal year 2022
financial results at 4:30 p.m. Eastern Time today, February 16,
2022. To access the conference call, dial (833) 614-1408 for the
U.S. or Canada, or for international callers (914) 987-7129 and
provide conference ID 3209898. The webcast will be available live
on the investors section of ibex’s website
at: https://investors.ibex.co/.
An audio replay of the call will also be
available to investors beginning at approximately 7:30 p.m. Eastern
Time on February 16, 2022, until 7:30 p.m. Eastern Time on February
23, 2022, by dialing (855) 859-2056 for the U.S. or Canada, or for
international callers, (404) 537-3406 and entering passcode
3209898. In addition, an archived webcast will be available on the
Investors section of ibex’s website
at: https://investors.ibex.co/.
Financial Information
This announcement does not contain sufficient
information to constitute an interim financial report as defined in
International Accounting Standards 34, “Interim Financial
Reporting.” The financial information in this press release has not
been audited.
Non-GAAP Financial Measures
We present non-GAAP financial measures because
we believe that they and other similar measures are widely used by
certain investors, securities analysts and other interested parties
as supplemental measures of performance and liquidity. We also use
these measures internally to establish forecasts, budgets and
operational goals to manage and monitor our business, as well as
evaluate our underlying historical performance, as we believe that
these non-GAAP financial measures provide a more accurate depiction
of the performance of the business by encompassing only relevant
and manageable events, enabling us to evaluate and plan more
effectively for the future. The non-GAAP financial measures may not
be comparable to other similarly titled measures of other
companies, have limitations as analytical tools, and should not be
considered in isolation or as a substitute for analysis of our
operating results as reported under IFRS as issued by the IASB.
Non-GAAP financial measures and ratios are not measurements of our
performance, financial condition or liquidity under IFRS as issued
by the IASB and should not be considered as alternatives to
operating profit or net income / (loss) or as alternatives to cash
flow from operating, investing or financing activities for the
period, or any other performance measures, derived in accordance
with IFRS as issued by the IASB or any other generally accepted
accounting principles.
ibex is not providing a quantitative
reconciliation of forward-looking non-GAAP adjusted EBITDA to the
most directly comparable IFRS measure because it is unable to
predict with reasonable certainty the ultimate outcome of certain
significant items without unreasonable effort. These items include,
but are not limited to, non-recurring expenses, fair value
adjustments, and share-based compensation expense. These items are
uncertain, depend on various factors, and could have a material
impact on IFRS reported results for the guidance period.
About ibex
ibex helps the world’s preeminent brands more
effectively engage their customers with services ranging from
customer support, technical support, inbound/outbound sales,
business intelligence and analytics, digital demand generation, and
CX surveys and feedback analytics.
Forward Looking Statements
In addition to historical information, this
release contains “forward-looking statements” within the meaning of
the Private Securities Litigation Reform Act of 1995. In some
cases, you can identify forward-looking statements by terminology
such as “believe,” “may,” “will,” “estimate,” “continue,”
“anticipate,” “intend,” “should,” “plan,” “expect,” “predict,”
“potential,” or the negative of these terms or other similar
expressions. These statements include, but are not limited to,
statements regarding our future financial and operating
performance, including our outlook and guidance, and our
strategies, priorities and business plans. Our expectations and
beliefs regarding these matters may not materialize, and actual
results in future periods are subject to risks and uncertainties
that could cause actual results to differ materially from those
projected. Factors that could impact our actual results include:
developments relating to COVID-19; our ability to attract new
business and retain key clients; our ability to enter into
multi-year contracts with our clients at appropriate rates; the
potential for our clients or potential clients to consolidate; our
clients deciding to enter into or further expand their insourcing
activities; our ability to operate as an integrated company under
the ibex brand; our ability to manage portions of our business that
have long sales cycles and long implementation cycles that require
significant resources and working capital; our ability to manage
our international operations, particularly in Pakistan and the
Philippines and increasingly in Jamaica, Nicaragua, and Honduras;
our ability to comply with applicable laws and regulations,
including those regarding privacy, data protection and information
security; our ability to manage the inelasticity of our labor costs
relative to short-term movements in client demand; our ability to
realize the anticipated strategic and financial benefits of our
relationship with Amazon; our ability to recruit, engage, motivate,
manage and retain our global workforce; our ability to anticipate,
develop and implement information technology solutions that keep
pace with evolving industry standards and changing client demands;
our ability to maintain and enhance our reputation and brand; and
other factors discussed under the heading “Risk Factors” in our
annual report on Form 20-F filed with the U.S. Securities and
Exchange Commission on October 14, 2021 and any other risk factors
we include in subsequent reports on Form 6-K. Because of these
uncertainties, you should not make any investment decisions based
on our estimates and forward-looking statements. Except as required
by law, we undertake no obligation to publicly update any
forward-looking statements for any reason after the date of this
press release whether as a result of new information, future events
or otherwise.
IR Contact: Daniel Bellehsen,
Executive Vice President, Investor Relations & Corporate
Development, ibex, Dan.Bellehsen@ibex.co
IBEX LimitedUnaudited
Consolidated Statements of Financial Position
|
|
|
|
|
|
|
December 31, |
|
June 30, |
US$ in
thousands |
2021 |
|
|
2021 |
|
|
|
Assets |
|
|
|
|
|
Current
assets |
|
|
|
|
|
Cash and cash equivalents |
$ |
51,531 |
|
|
$ |
57,842 |
|
Trade and other receivables |
|
103,788 |
|
|
|
81,104 |
|
Due from related parties |
|
1,239 |
|
|
|
1,755 |
|
Warrant asset |
|
869 |
|
|
|
673 |
|
Total current
assets |
$ |
157,427 |
|
|
$ |
141,374 |
|
|
|
|
|
|
|
Non-current
assets |
|
|
|
|
|
Property and equipment |
$ |
40,989 |
|
|
$ |
30,828 |
|
Right of use assets |
|
79,680 |
|
|
|
75,875 |
|
Goodwill |
|
11,832 |
|
|
|
11,832 |
|
Other intangible assets |
|
3,389 |
|
|
|
3,209 |
|
Warrant asset |
|
1,281 |
|
|
|
1,420 |
|
Investment in joint venture |
|
260 |
|
|
|
258 |
|
Deferred tax asset |
|
3,374 |
|
|
|
4,252 |
|
Other assets |
|
5,438 |
|
|
|
5,239 |
|
Total non-current
assets |
$ |
146,243 |
|
|
$ |
132,913 |
|
Total
assets |
$ |
303,670 |
|
|
$ |
274,287 |
|
|
|
|
|
|
|
Liabilities and
equity |
|
|
|
|
|
Current
liabilities |
|
|
|
|
|
Trade and other payables |
$ |
60,722 |
|
|
$ |
54,863 |
|
Deferred revenue |
|
7,856 |
|
|
|
4,077 |
|
Lease liabilities |
|
13,357 |
|
|
|
12,121 |
|
Borrowings |
|
37,108 |
|
|
|
26,716 |
|
Due to related parties |
|
3,706 |
|
|
|
4,275 |
|
Income tax payables |
|
2,400 |
|
|
|
3,663 |
|
Total current
liabilities |
$ |
125,149 |
|
|
$ |
105,715 |
|
|
|
|
|
|
|
Non-current
liabilities |
|
|
|
|
|
Deferred revenue |
$ |
4,583 |
|
|
$ |
3,010 |
|
Lease liabilities |
|
76,025 |
|
|
|
71,878 |
|
Borrowings |
|
570 |
|
|
|
1,801 |
|
Deferred tax liability |
|
86 |
|
|
|
86 |
|
Other non-current liabilities |
|
5,090 |
|
|
|
11,138 |
|
Total non-current
liabilities |
$ |
86,354 |
|
|
$ |
87,913 |
|
Total
liabilities |
$ |
211,503 |
|
|
$ |
193,628 |
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
Share capital |
$ |
2 |
|
|
$ |
2 |
|
Additional paid-in capital |
|
158,024 |
|
|
|
158,157 |
|
Other reserves |
|
33,342 |
|
|
|
33,180 |
|
Accumulated deficit |
|
(99,201 |
) |
|
|
(110,680 |
) |
Total
equity |
$ |
92,167 |
|
|
$ |
80,659 |
|
Total liabilities and
equity |
$ |
303,670 |
|
|
$ |
274,287 |
|
|
|
|
|
|
|
IBEX LimitedUnaudited
Consolidated Statements of Profit or Loss and
Other Comprehensive Income / (Loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended December 31, |
|
Six months ended December 31, |
US$ in
thousands, except share and per share amounts |
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
Revenue |
$ |
132,184 |
|
|
$ |
117,181 |
|
|
$ |
240,757 |
|
|
$ |
225,952 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Payroll and related costs |
|
91,491 |
|
|
|
78,960 |
|
|
|
167,928 |
|
|
|
151,224 |
|
Share-based
payments |
|
144 |
|
|
|
617 |
|
|
|
504 |
|
|
|
2,706 |
|
Reseller commission and lead
expenses |
|
3,489 |
|
|
|
3,399 |
|
|
|
6,681 |
|
|
|
7,501 |
|
Depreciation and
amortization |
|
8,669 |
|
|
|
6,983 |
|
|
|
16,312 |
|
|
|
13,422 |
|
Fair value measurement of
share warrants |
|
(4,187 |
) |
|
|
2,159 |
|
|
|
(6,987 |
) |
|
|
5,745 |
|
Other operating costs |
|
20,463 |
|
|
|
18,729 |
|
|
|
38,487 |
|
|
|
39,933 |
|
Income from
operations |
$ |
12,115 |
|
|
$ |
6,334 |
|
|
$ |
17,832 |
|
|
$ |
5,421 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Finance expenses |
$ |
(2,310 |
) |
|
$ |
(2,374 |
) |
|
|
(4,420 |
) |
|
|
(4,613 |
) |
Income before
taxation |
$ |
9,805 |
|
|
$ |
3,960 |
|
|
$ |
13,412 |
|
|
$ |
808 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense |
$ |
(1,340 |
) |
|
$ |
(1,472 |
) |
|
|
(1,933 |
) |
|
|
(1,743 |
) |
Net income /
(loss) |
$ |
8,465 |
|
|
$ |
2,488 |
|
|
$ |
11,479 |
|
|
$ |
(935 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive
income / (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Items that will be
subsequently reclassified to profit or loss |
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation
adjustment |
$ |
(157 |
) |
|
$ |
(77 |
) |
|
$ |
(602 |
) |
|
$ |
(113 |
) |
Cash flow hedges - changes in
fair value |
|
29 |
|
|
|
52 |
|
|
|
(282 |
) |
|
|
85 |
|
|
$ |
(128 |
) |
|
$ |
(25 |
) |
|
$ |
(884 |
) |
|
$ |
(28 |
) |
Total comprehensive
income / (loss) |
$ |
8,337 |
|
|
$ |
2,463 |
|
|
$ |
10,595 |
|
|
$ |
(963 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Earnings / (loss) per
share |
|
|
|
|
|
|
|
|
|
|
|
Basic |
$ |
0.46 |
|
|
$ |
0.14 |
|
|
$ |
0.63 |
|
|
$ |
(0.05 |
) |
Diluted |
$ |
0.45 |
|
|
$ |
0.13 |
|
|
$ |
0.61 |
|
|
$ |
(0.05 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average
shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
18,294,304 |
|
|
|
17,988,508 |
|
|
|
18,270,488 |
|
|
|
17,183,501 |
|
Diluted |
|
18,815,099 |
|
|
|
18,719,169 |
|
|
|
18,884,220 |
|
|
|
17,931,867 |
|
IBEX LimitedUnaudited
Consolidated Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended December 31, |
|
Six months ended December 31, |
US$ in
thousands |
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
CASH FLOWS FROM
OPERATING ACTIVITIES |
|
|
|
|
|
|
|
|
|
|
|
Income before taxation |
$ |
9,805 |
|
|
$ |
3,960 |
|
|
$ |
13,412 |
|
|
$ |
808 |
|
Adjustments to reconcile income before taxation to net cash
provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
8,669 |
|
|
|
6,983 |
|
|
|
16,312 |
|
|
|
13,422 |
|
Amortization of warrant asset |
|
237 |
|
|
|
243 |
|
|
|
(57 |
) |
|
|
448 |
|
Foreign currency translation loss / (gain) |
|
16 |
|
|
|
55 |
|
|
|
(6 |
) |
|
|
203 |
|
Fair value measurement of share warrants |
|
(4,187 |
) |
|
|
2,159 |
|
|
|
(6,987 |
) |
|
|
5,745 |
|
Share-based payments |
|
144 |
|
|
|
617 |
|
|
|
504 |
|
|
|
2,706 |
|
Allowance of expected credit losses |
|
(99 |
) |
|
|
209 |
|
|
|
(324 |
) |
|
|
452 |
|
Share of profit from investment in joint venture |
|
(211 |
) |
|
|
(103 |
) |
|
|
(436 |
) |
|
|
(226 |
) |
Gain on lease terminations |
|
(5 |
) |
|
|
- |
|
|
|
(7 |
) |
|
|
(192 |
) |
Provision for defined benefit scheme |
|
59 |
|
|
|
66 |
|
|
|
78 |
|
|
|
144 |
|
Finance expenses |
|
2,310 |
|
|
|
2,374 |
|
|
|
4,420 |
|
|
|
4,613 |
|
Increase in trade and other receivables |
|
(14,352 |
) |
|
|
(257 |
) |
|
|
(21,949 |
) |
|
|
(10,984 |
) |
Decrease / (increase) in prepayments and other assets |
|
70 |
|
|
|
(381 |
) |
|
|
(199 |
) |
|
|
(697 |
) |
Increase / (decrease) in trade and other payables and other
liabilities |
|
3,916 |
|
|
|
(8,101 |
) |
|
|
10,832 |
|
|
|
1,052 |
|
Cash inflow from operations |
|
6,372 |
|
|
|
7,824 |
|
|
|
15,593 |
|
|
|
17,494 |
|
Interest paid |
|
(2,310 |
) |
|
|
(2,374 |
) |
|
|
(4,420 |
) |
|
|
(4,613 |
) |
Income taxes paid |
|
(675 |
) |
|
|
(1,163 |
) |
|
|
(888 |
) |
|
|
(2,655 |
) |
Net cash inflow from operating activities |
$ |
3,387 |
|
|
$ |
4,287 |
|
|
$ |
10,285 |
|
|
$ |
10,226 |
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM
INVESTING ACTIVITIES |
|
|
|
|
|
|
|
|
|
|
|
Purchase of property and equipment |
$ |
(11,330 |
) |
|
$ |
(5,804 |
) |
|
$ |
(16,265 |
) |
|
$ |
(8,705 |
) |
Purchase of other intangible assets |
|
(487 |
) |
|
|
(557 |
) |
|
|
(876 |
) |
|
|
(867 |
) |
Dividend received from joint venture |
|
228 |
|
|
|
112 |
|
|
|
433 |
|
|
|
227 |
|
Net cash outflow from
investing activities |
$ |
(11,589 |
) |
|
$ |
(6,249 |
) |
|
$ |
(16,708 |
) |
|
$ |
(9,345 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM
FINANCING ACTIVITIES |
|
|
|
|
|
|
|
|
|
|
|
Proceeds from line of credit |
$ |
35,317 |
|
|
$ |
34,231 |
|
|
$ |
60,132 |
|
|
$ |
66,575 |
|
Repayments of line of credit |
|
(24,307 |
) |
|
|
(23,908 |
) |
|
|
(49,227 |
) |
|
|
(55,296 |
) |
Proceeds from borrowings |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,714 |
|
Repayment of borrowings |
|
(1,604 |
) |
|
|
(3,031 |
) |
|
|
(3,842 |
) |
|
|
(5,827 |
) |
Payment of related party loans |
|
- |
|
|
|
(1,614 |
) |
|
|
- |
|
|
|
(1,614 |
) |
Net proceeds from initial public offering |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
63,107 |
|
Payment of listing related costs |
|
- |
|
|
|
(227 |
) |
|
|
- |
|
|
|
(1,052 |
) |
Principal payments on lease obligations |
|
(3,524 |
) |
|
|
(8,575 |
) |
|
|
(6,547 |
) |
|
|
(11,630 |
) |
Dividend distribution |
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
(4,000 |
) |
Purchase of treasury shares |
|
(36 |
) |
|
|
- |
|
|
|
(36 |
) |
|
|
- |
|
Net cash inflow /
(outflow) from financing activities |
$ |
5,846 |
|
|
$ |
(3,124 |
) |
|
$ |
480 |
|
|
$ |
51,977 |
|
Effects of exchange rate difference on cash and cash
equivalents |
|
(99 |
) |
|
|
(78 |
) |
|
|
(368 |
) |
|
|
(113 |
) |
Net (decrease) / increase in cash and cash equivalents |
$ |
(2,455 |
) |
|
$ |
(5,164 |
) |
|
$ |
(6,311 |
) |
|
$ |
52,745 |
|
Cash and cash equivalents at beginning of the period |
$ |
53,986 |
|
|
$ |
79,779 |
|
|
$ |
57,842 |
|
|
$ |
21,870 |
|
Cash and cash
equivalents at end of the period |
$ |
51,531 |
|
|
$ |
74,615 |
|
|
$ |
51,531 |
|
|
$ |
74,615 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash
items |
|
|
|
|
|
|
|
|
|
|
|
New leases |
|
6,656 |
|
|
|
11,168 |
|
|
|
14,406 |
|
|
|
21,530 |
|
Change in accounts payable related to fixed assets |
|
(2,282 |
) |
|
|
- |
|
|
|
2,057 |
|
|
|
- |
|
IBEX
LimitedReconciliation of IFRS Financial Measures
to Non-GAAP Financial Measures
EXHIBIT 1: Adjusted net income and adjusted fully
diluted earnings per shareWe define “adjusted net income”
as net income / (loss) before the effect of the following items:
non-recurring expenses (including litigation and settlement
expenses, costs related to COVID-19, and listing costs, as
applicable), amortization of warrant asset, foreign currency
translation gains or losses, fair value measurement of share
warrants, share-based payments, gain or loss on disposal of fixed
assets and/or lease terminations, and impairment of intangibles, as
applicable, net of the tax impact of such adjustments. The
following table provides a reconciliation of net income / (loss) to
adjusted net income for the periods presented:
|
Three months ended December 31, |
Six months ended December 31, |
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|
|
US$ in thousands, except share and per share amounts,
unaudited |
Amount |
Per Share |
Amount |
Per Share |
Amount |
Per Share |
Amount |
|
Per Share |
|
Net income / (loss) |
$ |
8,465 |
|
$ |
0.45 |
|
$ |
2,488 |
|
$ |
0.13 |
|
$ |
11,479 |
|
$ |
0.61 |
|
$ |
(935 |
) |
|
$ |
(0.05 |
) |
(b) |
Non-recurring expenses |
|
850 |
|
|
0.05 |
|
|
1,593 |
|
|
0.09 |
|
|
1,712 |
|
|
0.09 |
|
|
5,991 |
|
|
|
0.33 |
|
|
Amortization of warrant asset |
|
237 |
|
|
0.01 |
|
|
243 |
|
|
0.01 |
|
|
(57 |
) |
|
(0.01 |
) |
|
448 |
|
|
|
0.03 |
|
|
Foreign
currency translation (gain) / loss |
|
16 |
|
|
0.00 |
|
|
55 |
|
|
0.00 |
|
|
(6 |
) |
|
(0.00 |
) |
|
203 |
|
|
|
0.01 |
|
|
Fair
value measurement of share warrants |
|
(4,187 |
) |
|
(0.23 |
) |
|
2,159 |
|
|
0.12 |
|
|
(6,987 |
) |
|
(0.37 |
) |
|
5,745 |
|
|
|
0.32 |
|
|
Share-based payments |
|
144 |
|
|
0.01 |
|
|
617 |
|
|
0.03 |
|
|
504 |
|
|
0.03 |
|
|
2,706 |
|
|
|
0.15 |
|
|
Gain on
lease terminations |
|
(5 |
) |
|
(0.00 |
) |
|
- |
|
|
- |
|
|
(7 |
) |
|
(0.00 |
) |
|
(192 |
) |
|
|
(0.01 |
) |
|
Total adjustments |
$ |
(2,945 |
) |
$ |
(0.16 |
) |
$ |
4,667 |
|
$ |
0.25 |
|
$ |
(4,841 |
) |
$ |
(0.26 |
) |
$ |
14,901 |
|
|
$ |
0.83 |
|
|
Tax
impact of adjustments(a) |
|
(346 |
) |
|
(0.02 |
) |
|
(1,016 |
) |
|
(0.05 |
) |
|
(595 |
) |
|
(0.03 |
) |
|
(2,376 |
) |
|
|
(0.13 |
) |
|
Adjusted net income |
$ |
5,174 |
|
$ |
0.27 |
|
$ |
6,139 |
|
$ |
0.33 |
|
$ |
6,043 |
|
$ |
0.32 |
|
$ |
11,590 |
|
|
$ |
0.65 |
|
|
Adjusted net income margin |
|
3.9 |
% |
|
|
|
5.2 |
% |
|
|
|
2.5 |
% |
|
|
|
5.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding - basic |
|
18,294,304 |
|
|
0.28 |
|
|
17,988,508 |
|
|
0.34 |
|
|
18,270,488 |
|
|
0.33 |
|
|
17,183,501 |
|
|
|
0.68 |
|
|
Dilutive
impact of share-based compensation and the Amazon warrant |
|
520,795 |
|
|
(0.01 |
) |
|
730,661 |
|
|
(0.01 |
) |
|
613,732 |
|
|
(0.01 |
) |
|
748,366 |
|
|
|
(0.03 |
) |
|
Weighted average shares outstanding - diluted
and adjusted fully diluted earnings per share |
|
18,815,099 |
|
$ |
0.27 |
|
|
18,719,169 |
|
$ |
0.33 |
|
|
18,884,220 |
|
$ |
0.32 |
|
|
17,931,867 |
|
(c) |
$ |
0.65 |
|
|
(a) The tax
impact of each adjustment is calculated using the effective tax
rate in the relevant
jurisdictions. (b) For
the period noted, the amount represents net income divided by the
weighted average shares outstanding –
diluted. (c) The
weighted average shares outstanding – diluted for the six months
ended December 31, 2020 reflect an additional 748,366 shares that
are anti-dilutive on an IFRS basis.EXHIBIT 2: EBITDA and
Adjusted EBITDAWe define “EBITDA” as net income / (loss)
before the effect of the following items: finance expenses
(including finance expense related to right-of-use lease
liabilities), income tax expense, and depreciation and amortization
(including depreciation of right-of-use assets). We define
“Adjusted EBITDA” as EBITDA before the effect of the following
items: non-recurring expenses (including litigation and settlement
expenses, costs related to COVID-19, and listing costs, as
applicable), amortization of warrant asset, foreign currency
translation gains or losses, fair value measurement of share
warrants, share-based payments, gain or loss on disposal of fixed
assets and/or lease terminations, and impairment of intangibles, as
applicable. The following table provides a reconciliation of net
income / (loss) to adjusted EBITDA for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended December 31, |
|
Six months ended December 31, |
US$ in
thousands, unaudited |
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
Net income / (loss) |
|
$ |
8,465 |
|
|
$ |
2,488 |
|
|
$ |
11,479 |
|
|
$ |
(935 |
) |
Finance expenses |
|
|
2,310 |
|
|
|
2,374 |
|
|
|
4,420 |
|
|
|
4,613 |
|
Income tax expense |
|
|
1,340 |
|
|
|
1,472 |
|
|
|
1,933 |
|
|
|
1,743 |
|
Depreciation and
amortization |
|
|
8,669 |
|
|
|
6,983 |
|
|
|
16,312 |
|
|
|
13,422 |
|
EBITDA |
|
$ |
20,784 |
|
|
$ |
13,317 |
|
|
$ |
34,144 |
|
|
$ |
18,843 |
|
Non-recurring expenses |
|
|
850 |
|
|
|
1,593 |
|
|
|
1,712 |
|
|
|
5,991 |
|
Amortization of warrant
asset |
|
|
237 |
|
|
|
243 |
|
|
|
(57 |
) |
|
|
448 |
|
Foreign currency translation
(gain) / loss |
|
|
16 |
|
|
|
55 |
|
|
|
(6 |
) |
|
|
203 |
|
Fair value measurement of
share warrants |
|
|
(4,187 |
) |
|
|
2,159 |
|
|
|
(6,987 |
) |
|
|
5,745 |
|
Share-based payments |
|
|
144 |
|
|
|
617 |
|
|
|
504 |
|
|
|
2,706 |
|
Gain on lease
terminations |
|
|
(5 |
) |
|
|
- |
|
|
|
(7 |
) |
|
|
(192 |
) |
Adjusted
EBITDA |
|
$ |
17,839 |
|
|
$ |
17,984 |
|
|
|
29,303 |
|
|
|
33,744 |
|
Adjusted EBITDA margin |
|
|
13.5 |
% |
|
|
15.3 |
% |
|
|
12.2 |
% |
|
|
14.9 |
% |
EXHIBIT 3: Free cash flowWe define “free cash
flow” as net cash provided by operating activities less cash
capital expenditures.
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended December 31, |
|
Six months ended December 31, |
US$ in
thousands, unaudited |
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
$ |
3,387 |
|
|
$ |
4,287 |
|
|
$ |
10,285 |
|
|
$ |
10,226 |
|
|
|
|
|
|
|
|
|
|
|
|
Less: |
|
|
|
|
|
|
|
|
|
|
|
Cash capital expenditures |
|
11,817 |
|
|
|
6,361 |
|
|
|
17,141 |
|
|
|
9,572 |
Free cash
flow(1) |
$ |
(8,430 |
) |
|
$ |
(2,074 |
) |
|
$ |
(6,856 |
) |
|
$ |
654 |
(1) Excluded from free cash flow are the
principal portion of right-of-use lease payments of $3,411 and
$2,843 for the quarter ended and $6,426 and $5,171 for the six
months ended December 31, 2021 and 2020, respectively. We believe
it is useful to consider these payments when analyzing free cash
flow as these amounts directly relate to revenue generating assets
used in operations.
EXHIBIT 4: Net debtWe define
“net debt” as total debt less cash and cash equivalents.
|
|
|
|
|
|
|
|
December 31, |
|
|
June 30, |
US$ in
thousands, unaudited |
|
2021 |
|
|
2021 |
Borrowings |
|
|
|
|
|
Current |
$ |
37,108 |
|
$ |
26,716 |
Non-current |
|
570 |
|
|
1,801 |
|
$ |
37,678 |
|
$ |
28,517 |
Leases |
|
|
|
|
|
Current |
$ |
13,357 |
|
$ |
12,121 |
Non-current |
|
76,025 |
|
|
71,878 |
|
$ |
89,382 |
|
$ |
83,999 |
Total debt |
$ |
127,060 |
|
$ |
112,516 |
Cash and cash equivalents |
|
51,531 |
|
|
57,842 |
Net debt |
$ |
75,529 |
|
$ |
54,674 |
IBEX (NASDAQ:IBEX)
Historical Stock Chart
From May 2024 to Jun 2024
IBEX (NASDAQ:IBEX)
Historical Stock Chart
From Jun 2023 to Jun 2024